Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anastasis Stephanou

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
The International Journal of Biochemistry & Cell Biology|October 12, 2010
Transgenic overexpression of HSP56 does not result in cardiac hypertrophy nor protect from ischaemia/reperfusion injuryChristopher J Carroll, Naushaad Suleman, Sean M Davidson, et al.
Journal of the American College of Cardiology|March 5, 2004
Minocycline inhibits caspase activation and reactivation, increases the ratio of XIAP to smac/DIABLO, and reduces the mitochondrial leakage of cytochrome C and smac/DIABLOTiziano M Scarabelli, Anastasis Stephanou, Evasio Pasini, et al.
Journal of Molecular and Cellular Cardiology|May 16, 2006
Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes exposed to ischaemia/reperfusion injuryLauren Valentim, Kevin M Laurence, Paul A Townsend, et al.
Biochemical and Biophysical Research Communications|September 11, 2004
The cardioprotective effect of urocortin during ischaemia/reperfusion involves the prevention of mitochondrial damageKevin M Lawrence, Paul A Townsend, Sean M Davidson, et al.
Chembiochem : a European Journal of Chemical Biology|December 14, 2004
The transcriptional coactivator p300 plays a critical role in the hypertrophic and protective pathways induced by phenylephrine in cardiac cells but is specific to the hypertrophic effect of urocortinSean M Davidson, Paul A Townsend, Chris Carroll, et al.
Cell Death & Disease|July 11, 2018
Annonacin promotes selective cancer cell death via NKA-dependent and SERCA-dependent pathwaysAndreas Yiallouris, Ioannis Patrikios, Elizabeth O Johnson, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 24, 2014
Diabetic hearts have lower basal urocortin levels that fail to increase after cardioplegic arrest: association with increased apoptosis and postsurgical cardiac dysfunctionCarol Chen-Scarabelli, Richard Knight, Anastasis Stephanou, et al.
Cell Death & Disease|September 20, 2022
Retraction Note: Annonacin promotes selective cancer cell death via NKA-dependent and SERCA-dependent pathwaysAndreas Yiallouris, Ioannis Patrikios, Elizabeth O Johnson, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 29, 2006
Free radical scavenging inhibits STAT phosphorylation following in vivo ischemia/reperfusion injuryJames McCormick, Sean P Barry, Ahila Sivarajah, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 8, 2007
Urocortin prevents mitochondrial permeability transition in response to reperfusion injury indirectly by reducing oxidative stressPaul A Townsend, Sean M Davidson, Samantha J Clarke, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
The International Journal of Biochemistry & Cell Biology|October 12, 2010
Transgenic overexpression of HSP56 does not result in cardiac hypertrophy nor protect from ischaemia/reperfusion injuryChristopher J Carroll, Naushaad Suleman, Sean M Davidson, et al.
Journal of the American College of Cardiology|March 5, 2004
Minocycline inhibits caspase activation and reactivation, increases the ratio of XIAP to smac/DIABLO, and reduces the mitochondrial leakage of cytochrome C and smac/DIABLOTiziano M Scarabelli, Anastasis Stephanou, Evasio Pasini, et al.
Journal of Molecular and Cellular Cardiology|May 16, 2006
Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes exposed to ischaemia/reperfusion injuryLauren Valentim, Kevin M Laurence, Paul A Townsend, et al.
Biochemical and Biophysical Research Communications|September 11, 2004
The cardioprotective effect of urocortin during ischaemia/reperfusion involves the prevention of mitochondrial damageKevin M Lawrence, Paul A Townsend, Sean M Davidson, et al.
Chembiochem : a European Journal of Chemical Biology|December 14, 2004
The transcriptional coactivator p300 plays a critical role in the hypertrophic and protective pathways induced by phenylephrine in cardiac cells but is specific to the hypertrophic effect of urocortinSean M Davidson, Paul A Townsend, Chris Carroll, et al.
Cell Death & Disease|July 11, 2018
Annonacin promotes selective cancer cell death via NKA-dependent and SERCA-dependent pathwaysAndreas Yiallouris, Ioannis Patrikios, Elizabeth O Johnson, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 24, 2014
Diabetic hearts have lower basal urocortin levels that fail to increase after cardioplegic arrest: association with increased apoptosis and postsurgical cardiac dysfunctionCarol Chen-Scarabelli, Richard Knight, Anastasis Stephanou, et al.
Cell Death & Disease|September 20, 2022
Retraction Note: Annonacin promotes selective cancer cell death via NKA-dependent and SERCA-dependent pathwaysAndreas Yiallouris, Ioannis Patrikios, Elizabeth O Johnson, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 29, 2006
Free radical scavenging inhibits STAT phosphorylation following in vivo ischemia/reperfusion injuryJames McCormick, Sean P Barry, Ahila Sivarajah, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 8, 2007
Urocortin prevents mitochondrial permeability transition in response to reperfusion injury indirectly by reducing oxidative stressPaul A Townsend, Sean M Davidson, Samantha J Clarke, et al.
Pageof 8